Matthew Lunning
DO
Associate Professor, Division of Hematology/Oncology
👥Biography 个人简介
Matthew Lunning is a lymphoma researcher who has contributed to bispecific antibody development for DLBCL including epcoritamab and glofitamab trials. His work on subcutaneous bispecific antibody administration has improved convenience of treatment delivery. He has been an advocate for timely community referral pathways for CAR-T cell therapy.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Matthew Lunning 的研究动态
Follow Matthew Lunning's research updates
留下邮箱，当我们发布与 Matthew Lunning（University of Nebraska Medical Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment